-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MOQGUr5t7dIsqAf+KyPA/BQP/BQz9kU4Lv8KRXTLZk0fn5Vwj0Xle2JA49mFEBkW A9SIzN/Jo+BJ2FFepSh8Vw== 0001193125-04-162896.txt : 20040928 0001193125-04-162896.hdr.sgml : 20040928 20040928115651 ACCESSION NUMBER: 0001193125-04-162896 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20040928 DATE AS OF CHANGE: 20040928 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SUPERGEN INC CENTRAL INDEX KEY: 0000919722 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911841574 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-48769 FILM NUMBER: 041048896 BUSINESS ADDRESS: STREET 1: 4140 DUBLIN BLVD STREET 2: SUITE 200 CITY: DUBLIN STATE: CA ZIP: 94568 BUSINESS PHONE: 9255600100 MAIL ADDRESS: STREET 1: 4140 DUBLIN BLVD STREET 2: STE 200 CITY: DUBLIN STATE: CA ZIP: 94568 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MGI PHARMA INC CENTRAL INDEX KEY: 0000702131 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411364647 STATE OF INCORPORATION: MN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 5775 WEST OLD SHAKOPEE RD STREET 2: SUITE 100 CITY: BLOOMINGTON STATE: MN ZIP: 55437 BUSINESS PHONE: 952-346-4700 MAIL ADDRESS: STREET 1: 5775 WEST OLD SHAKOPEE RD STREET 2: SUITE 100 CITY: MINNEAPOLIS STATE: MN ZIP: 55437 FORMER COMPANY: FORMER CONFORMED NAME: MOLECULAR GENETICS INC DATE OF NAME CHANGE: 19900812 SC 13G 1 dsc13g.txt SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 SuperGen, Inc. (Name of Issuer) Common Stock, $.001 (Title of Class of Securities) 868059 10 6 (CUSIP Number) September 21, 2004 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [X] Rule 13d-1(c) [ ] Rule 13d-1(d) 13G CUSIP NO. 868059 10 6 1. Name of reporting persons MGI PHARMA, Inc. I.R.S. Identification Nos. of above persons (entities only): 41-1364647 2. Check the appropriate box if a member of a group (a) [ ] (b) [ ] 3. SEC use only 4. Citizenship or place of organization: Minnesota Number of shares beneficially owned by each reporting person with 5. Sole voting power 4,000,000 6. Shared voting power 0 7. Sole dispositive power 4,000,000 8. Shared dispositive power 0 9. Aggregate amount beneficially owned by each reporting person 4,000,000 10. Check if the aggregate amount in Row (9) excludes certain shares [ ] 11. Percent of class represented by amount in Row 9 8.8% 12. Type of reporting person CO Item 1(a)-(b). Name and principal executive office of issuer: SuperGen, Inc. 4140 Dublin Boulevard, Suite 200 Dublin, CA 94568 Item 2(a)-(c). Name, principal executive office and citizenship of person filing: MGI PHARMA, Inc., a Minnesota corporation 5775 West Old Shakopee Road, Suite 100 Bloomington, MN 55437 Item 2(d). Title of class of securities: Common Stock, $.001 par value Item 2(e). CUSIP No.: 868059 10 6 Item 3. If this statement is filed pursuant to Secs. 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: Not Applicable Item 4. Ownership (a) Amount beneficially owned: 4,000,000 (b) Percent of class: 8.8% (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: 4,000,000 (ii) Shared power to vote or to direct the vote: 0 (iii) Sole power to dispose or to direct the disposition of: 4,000,000 (iv) Shared power to dispose or to direct the disposition of: 0 Item 5. Ownership of 5 percent or Less of a Class Not applicable Item 6. Ownership of More than 5 Percent on Behalf of Another Person Not Applicable Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person Not Applicable Item 8. Identification and Classification of Members of the Group Not Applicable Item 9. Notice of Dissolution of Group Not Applicable Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: September 27, 2004 /s/ William C. Brown --------------------------------------- Signature William C. Brown Executive Vice President and CFO Name/Title -----END PRIVACY-ENHANCED MESSAGE-----